AVDWF yields 13.77% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, AVDWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVDWF + PFE for your $10,000?
Advent-AWI Holdings Inc., together with its subsidiaries, sells cellular and wireless products, services, and accessories in Canada. It operates through three segments: Wireless Business, Financing Business, and Digital Health Business. The Wireless Business segment offers wireless voice and data, high speed internet, digital cable television, home phone, smart home monitoring, and Rogers Bank Mastercard products. As of December 31, 2021, it had 4 stores, including 2 Rogers and 2 Fido stores in Ontario. The Financing Business segment provides personal and collateral loans across the Greater Vancouver and Greater Toronto Areas. The Digital Health Business segment offers digital health products and services, including handheld health scanners, which are wirelessly connected with cloud based artificial intelligence through channel customized software and mobile applications to monitor heart rate, blood pressure, blood oxygen saturation levels, respiratory lung analysis, body temperature, and body composition; and IT support services to consumers and health care providers in Hong Kong and Macau. The company was formerly known as Advent Wireless Inc. and changed its name to Advent-AWI Holdings Inc. in March 2017. Advent-AWI Holdings Inc. was incorporated in 1984 and is based in Vancouver, Canada.
Full AVDWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.